Advanced stage primary mucinous ovarian carcinoma. Where do we stand ?
Sign Up to like & getrecommendations! Published in 2020 at "Archives of Gynecology and Obstetrics"
DOI: 10.1007/s00404-020-05489-3
Abstract: Objective To evaluate factors associated with survival of patients with advanced stage mucinous ovarian carcinoma (MOC) using a large multi-institutional database. Methods Patients diagnosed between 2004 and 2014 with advanced stage (III–IV) MOC were identified… read more here.
Keywords: mucinous ovarian; advanced stage; stage primary; stage ... See more keywords
Reply to “Is there a promising role of HIPEC in patients with advanced mucinous ovarian cancer?” by lavazzo et al
Sign Up to like & getrecommendations! Published in 2020 at "Archives of Gynecology and Obstetrics"
DOI: 10.1007/s00404-020-05647-7
Abstract: We thank Dr Iavazzo et al. for their interest in our paper [1]. We agree that the outcomes of patients with advanced mucinous ovarian carcinoma (MOC) are extremely poor. Our paper underlines the pivotal role… read more here.
Keywords: pathology; advanced mucinous; role; mucinous ovarian ... See more keywords
Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
Sign Up to like & getrecommendations! Published in 2018 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2018.07.013
Abstract: OBJECTIVE Advanced stage mucinous ovarian cancers are diagnostically and therapeutically challenging. Histotype specific trials have failed due to low recruitment after excluding non-ovarian primaries. Mucinous ovarian cancers are commonly metastatic from other sites however lack… read more here.
Keywords: cancers uncertain; treatment; ovarian cancers; clinical trials ... See more keywords
Impact of lymphadenectomy and intraoperative tumor rupture on survival in early-stage mucinous ovarian cancers
Sign Up to like & getrecommendations! Published in 2021 at "Gynecologic Oncology"
DOI: 10.1016/s0090-8258(21)00986-0
Abstract: Objectives: Mucinous ovarian carcinoma (MOC) is a rare subtype of epithelial ovarian cancer and often presents a management conundrum. The aim of the study was to investigate the prognostic significance of lymphadenectomy and intraoperative rupture… read more here.
Keywords: rupture; lymphadenectomy intraoperative; mucinous ovarian; stage ... See more keywords
Mural nodules in mucinous ovarian tumors represent a morphologic spectrum of clonal neoplasms: a morphologic, immunohistochemical, and molecular analysis of 13 cases
Sign Up to like & getrecommendations! Published in 2020 at "Modern Pathology"
DOI: 10.1038/s41379-020-0642-9
Abstract: Mucinous ovarian tumors rarely harbor mural nodules, which have historically been classified as sarcoma-like, anaplastic carcinomatous, or sarcomatous on the basis of predominant morphologic features. The molecular relationship between mural nodules and associated mucinous ovarian… read more here.
Keywords: ovarian tumors; mural nodules; sarcoma like; anaplastic carcinomatous ... See more keywords
Analysis of blood group antigens on MUC5AC in mucinous ovarian cancer tissues using in situ proximity ligation assay.
Sign Up to like & getrecommendations! Published in 2021 at "Glycobiology"
DOI: 10.1093/glycob/cwab090
Abstract: MUC5AC has been indicated to be a marker for mucinous ovarian cancer (OC). We investigated the use of in situ proximity ligation assay (PLA) for blood group ABH expressing MUC5AC to differentiate between serous and… read more here.
Keywords: pla; secretor; muc5ac; ovarian cancer ... See more keywords
Lymphadenectomy for early-stage mucinous ovarian carcinoma
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2020-001817
Abstract: Objectives There is evidence to suggest that the rate of lymph node metastases in patients with ovarian mucinous tumors is rare. The objective of this study was to investigate the prevalence of regional lymph node… read more here.
Keywords: stage mucinous; ovarian carcinoma; mucinous ovarian; lymph node ... See more keywords
A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2021-003104
Abstract: Objective Because mucinous carcinomas are rare tumors that affect several organ sites and are known to originate from different tissues, leading to frequent misdiagnoses, the objective was to characterize the differences between primary mucinous tumors… read more here.
Keywords: pax8; muc1 muc5ac; growth pattern; mucinous ovarian ... See more keywords
Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2022-003658
Abstract: Mucinous ovarian carcinoma is a rare subtype of epithelial ovarian cancer. Despite being a chemoresistant tumour type, surgical resection and chemotherapy are still the current standard for management. This narrative review aims to explore the… read more here.
Keywords: clinical trials; targeted therapy; mucinous ovarian; evidence ... See more keywords
A Nomogram Based on SEER Database for Predicting Prognosis in Patients with Mucinous Ovarian Cancer: A Real-World Study
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Women's Health"
DOI: 10.2147/ijwh.s372328
Abstract: Purpose Mucinous ovarian cancer (MOC) is a rare histological type of EOC. In order to guide the clinical diagnosis and management of MOC patients, we constructed and verified a nomogram for the estimation of overall… read more here.
Keywords: prognosis; ovarian cancer; seer database; mucinous ovarian ... See more keywords
Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15650
Abstract: Background/Aim: Mucinous ovarian carcinoma (mOC) is a rare subtype with distinct clinical characteristics and biological behavior that differentiate them from other epithelial ovarian cancers. This study aimed to evaluate BMI-1 expression as a potential target… read more here.
Keywords: mucinous ovarian; potential therapeutic; ovarian cancer; therapeutic target ... See more keywords